BHC
GILD icon

Bowen Hanes & Co’s Gilead Sciences GILD Stock Holding History

Bowen Hanes & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Sell
1,510
-1,510
-50% -$211K 0.01% 150
2025
Q4 		$371K Buy
+3,020
New +$367K 0.01% 139
2024
Q3 		– Sell
-4,510
Closed -$309K – 154
2024
Q2 		$309K Sell
4,510
-4,395
-49% -$293K 0.01% 135
2024
Q1 		$652K Hold
8,905
– – 0.02% 121
2023
Q4 		$721K Buy
8,905
+5,040
+130% +$392K 0.02% 114
2023
Q3 		$290K Sell
3,865
-5,700
-60% -$438K 0.01% 131
2023
Q2 		$737K Sell
9,565
-14,920
-61% -$1.19M 0.02% 110
2023
Q1 		$2.03M Buy
24,485
+6,710
+38% +$556K 0.07% 85
2022
Q4 		$1.53M Buy
+17,775
New +$1.41M 0.05% 100
2017
Q4 		– Sell
-4,175
Closed -$338K – 143
2017
Q3 		$338K Sell
4,175
-3,065
-42% -$234K 0.02% 130
2017
Q2 		$512K Sell
7,240
-856
-11% -$57K 0.03% 119
2017
Q1 		$550K Sell
8,096
-365
-4% -$25.7K 0.03% 115
2016
Q4 		$606K Sell
8,461
-2,880
-25% -$214K 0.03% 112
2016
Q3 		$897K Buy
11,341
+485
+4% +$39.4K 0.05% 103
2016
Q2 		$906K Buy
10,856
+1,405
+15% +$125K 0.05% 100
2016
Q1 		$868K Sell
9,451
-16,515
-64% -$1.49M 0.05% 98
2015
Q4 		$2.63M Sell
25,966
-212,438
-89% -$22.1M 0.15% 83
2015
Q3 		$23.4M Sell
238,404
-22,255
-9% -$2.47M 1.35% 32
2015
Q2 		$30.5M Sell
260,659
-33,202
-11% -$3.63M 1.52% 17
2015
Q1 		$28.8M Buy
293,861
+20
+0% +$2.03K 1.39% 24
2014
Q4 		$27.7M Sell
293,841
-52,225
-15% -$5.4M 1.36% 28
2014
Q3 		$36.8M Sell
346,066
-58,325
-14% -$5.71M 1.8% 5
2014
Q2 		$33.5M Buy
404,391
+12,221
+3% +$951K 1.56% 12
2014
Q1 		$27.8M Sell
392,170
-43,720
-10% -$3.43M 1.34% 25
2013
Q4 		$32.7M Sell
435,890
-99,455
-19% -$6.93M 1.59% 10
2013
Q3 		$33.7M Sell
535,345
-95,020
-15% -$5.68M 1.72% 9
2013
Q2 		$32.3M Buy
+630,365
New +$32.9M 1.73% 10

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bowen Hanes & Co's GILD Position: Q1 2026 in Review

Bowen Hanes & Co reduced its Gilead Sciences (GILD) stake by 50% in Q1 2026, selling an estimated $211K and leaving 1,510 shares worth $210K. The position accounts for 0.01% of the portfolio, ranked #150.

Bowen Hanes & Co first reported a position in GILD in Q2 2013 and has held it in 27 quarters since. The position peaked at $36.8M in Q3 2014. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Bowen Hanes & Co held 1,510 shares of Gilead Sciences worth $210K as of Q1 2026.
  • Bowen Hanes & Co sold 1,510 Gilead Sciences shares in Q1 2026, an estimated $211K.
  • Gilead Sciences made up 0.01% of Bowen Hanes & Co's portfolio in Q1 2026, its #150 holding.
  • Bowen Hanes & Co first reported a position in Gilead Sciences in Q2 2013 and has held it in 27 quarters since.
  • Bowen Hanes & Co's Gilead Sciences position peaked at $36.8M in Q3 2014.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Bowen Hanes & Co's 13F filing for Q1 2026, filed 14 May 2026.